Axitinib (Oral Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Axitinib (Oral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Inlyta

Description

Axitinib is an anticancer medicine that is used to treat kidney cancer (advanced renal cell carcinoma) in patients who have received at least one cancer treatment that did not work.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Tablet
Before Using
DR603593 Portions of this document last updated: July 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger